Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'BV' OR with Authors including 'BV' OR with Abstract including 'BV' OR with Keywords including 'BV'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Abramson HA, Evans LT, Ge... Bioassays for LSD-25 Annual Rep. Biol. La... 1954
Graham JDP, Khalidi AI The actions of d-lysergic acid diethylamide (L.S.D. 25).Part 2. Centra... J. Fac. Med. Iraq 1954
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Baldwin M, Lewis SA, Bach... The effects of lysergic acid after cerebral ablation. Neurology (Minneapol... 1959
Cerletti A Comparison of abnormal behavioral states induced by psychotropic drugs... Neuro-Psychopharmaco... 1959
Balestrieri A Studies on cross tolerance with LSD-25, UML-491 and JB-336 Psychopharmacologia 1960
Taeschler M, Cerletti A Zur Pharmakologie psychoaktiver Wirkstoffe Munchen. med. Wschr. 1960
Salvatore S Some Related Factors of the LSD 25 Reaction Psychiatric Quart. 1960
A Balestrieri Studies on cross tolerance with LSD-25, UML-491 and JB-336. Psychopharmacologia 1960
Brown BB CNS stimulants and electrical brain activity in spontaneously behaving... Fed. Proc. 1961
DJ Douche Les effets de la psilocybine dans un cas d'hysterie Semaine d. hop. 1961
Higginbottam J, Melton B Some new experiences with L.S.D Nursing Mirror 1961
Blinks JR Evaluation of the cardiac effects of several beta adrenergic blocking ... Ann N Y Acad Sci 1967
Hanus H, Preiningerosa O,... Nektere Mene obvykle psychopatologicke Priznaky intoxikace psilocybine... Activ Nerv Sup 1968
Anderson EG, Clineschmidt... Blokade of bulbospinal inhibition by antagonists of 5-hydroxytryptamin... Pharmacologist 1969
Clineschmidt BV, Anderson... The Blockade of bulbospinal inhibition by 5-hydroxytryptamine antagoni... Exp. Brain. Res. 1970
Dandiya PC, Chopra YM CNS-Active drugs from plants indigenous to India Ind. J. Pharmac. 1970
Fisher G, Martin AJ The Psychotherapeutic Use Of Psychodysleptic Drugs Voices: The Art and ... 1970
Goldenthal EI A compilation of LD50 values in newborn and adult animals Toxicol Appl Pharmac... 1971
Friedman SA, Hirsch SE Extreme hyperthermia after LSD ingestion JAMA 1971
Hester JB, Rudzik AD, Kam... 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central n... J Med Chem 1971
Gey KF, Georgi H Effect Of Neurotropic Agents On Total Pyridoxal, Phosphate And On The ... J Neurochem. 1974
Oliveras JL, Besson JM, G... Analgesia Induced by Electrical Stimulation of the Dorsal Raphe Nucleu... J. Pharmacol. 1974
Pieri M, Schaffner R, Hae... Central dopamine-receptor stimulation bv LSD and lisuride Experientia 1977
Siegel RK Pharmacology of Hallucinogens: HALLUCINOGENS AND ATTENTIONAL DYSFUNCTI... The Psychopharmacolo... 1978
Stoff DM, Gillin JC, Wyat... Animal Models Of Drug-induced Hallucinations The Psychopharmacolo... 1978
Shulgin AT Chemistry of phenethylamines related to mescaline J Psychedelic Drugs 1979
Macdermot J, Higashida H Independent Regulation of Receptor-Mediated Cell Depolarization and Ad... Biochem. Soc. Trans. 1979
Levine JD, Gordon NC, Bor... Role of pain in placebo analgesia Proc Natl Acad Sci U... 1979
Idvall J, Ahlgren I, Aron... Ketamine infusions: pharmacokinetics and clinical effects Br J Anaesth 1979
McLellan, AT, Woody GE, O... Psychiatric Illness in Drug Abusers New Engl. J. Med. 1980
McCall MA, Tieman DG, Hir... Chronic Intraventricular Administration of Lysergic Acid Diethylamide ... Brain Research 1982
Cheney BV, Szmuszkovicz J... Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzam... J Med Chem 1985
Seiden LS, Woolverton WL,... Behavioral consequences of partial monoamine depletion in the CNS afte... NIDA Res Monogr 1993
Pfaff RC, Huang X, Marona... Lysergamides Revisited NIDA Research Monogr... 1994
Chenard-Neu MP, Boudjema ... Auxiliary liver transplantation: regeneration of the native liver and ... Hepatology 1996
Murthy BV, Wilkes RG, Rob... Creatine kinase isoform changes following Ecstasy overdose Anaesth Intensive Ca... 1997
Murthy BV, Roberts NB, Wi... Biochemical implications of ecstasy toxicity Ann Clin Biochem 1997
Bengel D, Murphy DL, Andr... Altered brain serotonin homeostasis and locomotor insensitivity to 3, ... Mol Pharmacol 1998
D'Esposito M Serotonin neurotoxicity: implications for cognitive neuroscience and n... Neurology 1998
Lebot V, Johnston E, Zhe... Morphological, Phytochemical and Genetic Variation in Hawai'ian Cultiv... Economic Botany 1999
Erdtmann-Vourliotis M, Ma... Prior experience of morphine application alters the c-fos response to ... Brain Res Mol Brain ... 2000
Heffernan TM, Jarvis H, R... Prospective memory, everyday cognitive failure and central executive f... Hum Psychopharm Clin... 2001
Engelsman EL Cannabis Control: the model of the WHO tobacco control treaty International Journa... 2003
Mirken B, Earleywine M The cannabis and psychosis connection questioned: a comment on Ferguss... Addiction 2005
Ott J Obviation of opioid withdrawal syndrome by concomitant administration ... J Psychoactive Drugs 2006
Gillette R Evolution and Function in Serotonergic Systems Integrative and Comp... 2006
Olsen AK, Keiding S, Munk... Effect of hypercapnia on cerebral blood flow and blood volume in pigs ... Comp Med 2006
de Win MM, Reneman L, Jag... A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Us... Neuropsychopharmacol... 2006
Chen HI, Kuo YM, Liao CH,... Long-term compulsive exercise reduces the rewarding efficacy of 3,4-me... Behav Brain Res 2007
Halpern JH, Sherwood AR, ... Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) Addiction 2011
Venkatratnam A, Lents NH Zinc reduces the detection of cocaine, methamphetamine, and THC by ELI... J Anal Toxicol 2011
Petroczi A, Nepusz T, Cro... New non-randomised model to assess the prevalence of discriminating be... Subst Abuse Treat Pr... 2011
Neerman MF, Frost RE, Dek... A Drug Fatality Involving Kratom J Forensic Sci 2012
Wise RA, Koob GF The Development and Maintenance of Drug Addiction Neuropsychopharmacol... 2013
Chaboussant PJ, Gagez AL,... [Behavioural impairments and hallucinations after consumption of boldo... Therapie 2014
Moosmann B, Auwärter V Designer Benzodiazepines: Another Class of New Psychoactive Substances Handb Exp Pharmacol 2018
Passie T, Brandt SD Self-Experiments with Psychoactive Substances: A Historical Perspectiv... Handb Exp Pharmacol 2018
Haden M, Woods B LSD Overdoses: Three Case Reports J Stud Alcohol Drugs 2020